KROS R&D Expenses
Keros Therapeutics Inc · R&D Expenses
KROS R&D Expenses
Latest reported$75.86Mperiod ending
KROS TTM R&D Expenses ($17.38M → $75.86M)
TTM R&D Expenses
High-resolution chart · PNG
KROS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 75,859,000 | |
| 97,031,000 | |
| 129,643,000 | |
| 157,362,000 | |
| 187,068,000 | |
| 184,080,000 | |
| 173,629,000 | |
| 165,491,000 | |
| 150,406,000 | |
| 142,425,000 | |
| 135,258,000 | |
| 122,632,000 | |
| 109,531,000 | |
| 100,278,000 | |
| 87,265,000 | |
| 81,232,000 | |
| 75,025,000 | |
| 61,727,000 | |
| 55,144,000 | |
| 45,984,000 | |
| 39,547,000 | |
| 36,828,000 | |
| 33,860,000 | |
| 28,347,000 | |
| 23,806,000 | |
| 21,039,000 | |
| 17,379,000 |